Shares of AstraZeneca rose on Friday after the drugmaker reported positive results from late-stage clinical trials of its experimental chronic obstructive pulmonary disease (COPD) treatment, tozorakimab.The UK-based pharmaceutical company said the drug candidate met its primary objective in two Phase 3 studies, OBERON and TITANIA, marking a significant milestone in…
Lumentum stock price has gone vertical this year and is now trading at its all-time high. LITE jumped to…
Nvidia shares remain under pressure, tracking a broader pullback in artificial intelligence-linked stocks.The stock fell 1.8% in early trading…
Shares of Meta Platforms extended their selloff on Friday, as mounting legal setbacks weighed on investor sentiment, but the…
For the better part of a year, Wall Street has operated on a cynical yet profitable mantra – “Trump…
Shares of Tesla remained under pressure on Friday, extending a weak run as investors weighed softer delivery expectations, geopolitical…
Wall Street’s most persistent bull, Tom Lee, is doubling down on a vision of the future that would make…
Global markets closed the week on a cautious note, with multiple asset classes reflecting heightened uncertainty. The cryptocurrency market…
CrowdStrike Holdings Inc (NASDAQ: CRWD) is inching lower on Mar 27 after partner Anthropic previewed a “breakthrough” AI model…